Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ozgur Acikgoz"'
Autor:
Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin
Publikováno v:
Biomolecules & Biomedicine, Vol 23, Iss 6 (2023)
Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies. Our study aimed to evaluate prognostic factors influencing regorafenib treatment and assess t
Externí odkaz:
https://doaj.org/article/307cb5703f46446fb0e16815e2f38f8b
Autor:
Umut Kefeli, Aysegul Ucuncu Kefeli, Devrim Cabuk, Ulas Isik, Alper Sonkaya, Ozgur Acikgoz, Ercan Ozden, Kazim Uygun
Publikováno v:
Tumor Biology, Vol 39 (2017)
Netrin-1, a laminin-related protein, is known to be involved in the nervous system development. Recently, Netrin-1’s involvement in other processes such as cell adhesion, motility, proliferation, and differentiation that are important for the devel
Externí odkaz:
https://doaj.org/article/39c30be125254bd2a37636a80d546197
Autor:
Devrim Cabuk, Y. Taha Gullu, Ilknur Basyigit, Ozgur Acikgoz, Kazım Uygun, Kursat Yildiz, Fusun Yildiz
Publikováno v:
Case Reports in Pulmonology, Vol 2013 (2013)
Endobronchial involvement of extrapulmonary malignant tumors is uncommon and mostly associated with breast, kidney, colon, and rectum carcinomas. A 68-year-old male with a prior diagnosis of colon non-Hodgkin lymphoma (NHL) was admitted to the hospit
Externí odkaz:
https://doaj.org/article/0933b295c6f34799931580bdeb9f75d7
Autor:
Sabin Goktas Aydin, Ahmet Bilici, Omer Fatih Olmez, Basak B. Oven, Ozgur Acikgoz, Tansel Cakir, Pelin Basim, Asli Cakir, Yasin Kutlu, Jamshid Hamdard
Purpose: Patients with locally advanced breast cancer (LABC) should be treated with neoadjuvant chemotherapy (NAC). Pathological complete response (pCR) is related to better disease-free survival (DFS). The best strategy for assessing the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47834b600e2b05b50beb987f45771186
https://hdl.handle.net/20.500.12511/9947
https://hdl.handle.net/20.500.12511/9947
Autor:
Ozgur Acikgoz
Publikováno v:
Eurasian Journal of Medical Investigation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14bb60f5a1961d746b1a288951e2da56
https://doi.org/10.14744/ejmi.2021.09122
https://doi.org/10.14744/ejmi.2021.09122
Autor:
Ahmet Bilici, Mukremin Uysal, Serkan Menekse, Semih Akin, Fatih Yildiz, Merve Turan, Sema Sezgin Goksu, Ismail Beypinar, Teoman Sakalar, Mustafa Değirmenci, Dilek Erdem, Gul Basaran, Omer Fatih Olmez, Nilufer Avci, Deniz Tural, Abdullah Sakin, Sema Turker, Atakan Demir, Suleyman Temiz, Muhammed Ali Kaplan, Mutlu Dogan, Ozgur Tanriverdi, Irem Bilgetekin, Havva Yesil Cinkir, Ozgur Acikgoz, Semra Paydas, Ruchan Uslu, Serdar Turhal
© 2021 Taylor & Francis Group, LLC.Purpose: This study evaluated the efficacy and safety of everolimus (EVE) plus exemestane (EXE) in hormone-receptor positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) metastatic breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc88869b3476dea5a33f45cbc1f4df24
https://hdl.handle.net/11454/77155
https://hdl.handle.net/11454/77155
Autor:
Burcin, Cakan, Ozgur, Acikgoz, Ahmet, Bilici, Tarik, Demir, Bala, Basak Oven, Jamshid, Hamdard, Oktay, Olmuscelik, Omer Fatih, Olmez, Mesut, Seker, Ozcan, Yildiz
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
The purpose of this study was to investigate the prognostic value,and the effect of primary tumor location on targeted therapy selection in patients with metastatic colorectal cancer (mCRC).A total of 201 patients with de novo mCRC who received first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dab54989fa2be10848dfe72191773661
https://pubmed.ncbi.nlm.nih.gov/34761599
https://pubmed.ncbi.nlm.nih.gov/34761599
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(8)
Introduction Immune checkpoint inhibitors are drugs that are included in the guidelines of hematological and solid cancer treatments, give highly effective results and increase T cell functionality. However, these drugs can cause immune-related adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab44e158e09e61563ef99df9a68f349
https://pubmed.ncbi.nlm.nih.gov/34282980
https://pubmed.ncbi.nlm.nih.gov/34282980
Autor:
Umut Kefeli, Alper Sonkaya, Deniz Işik, Ercan Ozden, Ulas Isik, Dincer Aydin, Kazim Uygun, Devrim Cabuk, Samet Kaymaz, Ozgur Acikgoz
Publikováno v:
Bezmiâlem Science, Vol 7, Iss 4, Pp 265-270 (2019)
Objective:Early-stage non-small cell lung cancer (NSCLC) constitutes approximately 25-30% of newly diagnosed lung cancers. Elderly patients with NSCLC have generallly been underrepresented in clinical studies. We explored adjuvant chemotherapy result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d28b6c383275c7de090ac925eba03f2
https://doaj.org/article/2c619e7bae494c43a9f3eb3bbf6b9ca3
https://doaj.org/article/2c619e7bae494c43a9f3eb3bbf6b9ca3
Autor:
Burcak Yilmaz, Serap Nisli, Nurhan Ergül, Ozgur Acikgoz, Rıza Umar Gürsu, Tevfik Fikret Çermik
Publikováno v:
Journal of Nuclear Medicine. 60:1388-1393
Recent years have seen the start of treatment of metastatic castration-resistant prostate cancer with prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (PRLT), especially 177Lu-PSMA-617. However, PRLT has side effects on the sali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0d13a7b5d1c2bba1e48366a2251b10d
https://doi.org/10.2967/jnumed.119.226449
https://doi.org/10.2967/jnumed.119.226449